affects more than 500,000 Americans and is a chronic inflammatory condition that affects the digestive tract. Symptoms of Crohn's Disease include abdominal pain, diarrhea, fever, and loss of appetite. Unfortunately, there is no cure for Crohn's, but there are a number of treatments available to help control symptoms.

One of the newer treatments on the market is Otelza, a prescription drug specifically developed to treat Crohn's Disease. Unlike traditional medications for Crohn's, Otelza works by targeting specific chronic inflammation in the digestive tract, rather than just treating the symptoms. This unique approach provides longer-term relief from Crohn's symptoms, and also reduces the risk of potential adverse side effects.

Clinical research has been conducted on Otelza and results have been positive. In a study of 125 patients with Crohn's Disease, those taking Otelza reported significantly improved scores across all symptom severity measures. Patients taking the drug noted decreases in abdominal pain, diarrhea, and improved quality of life. Additionally, patients taking Otelza did not experience any serious adverse effects, making it a safer option than many other Crohn's treatments.

Overall, Otelza is an exciting new treatment option for people with Crohn's Disease. Its targeted approach makes it an ideal choice for those looking to reduce symptoms and improve their quality of life. It is important to talk to your doctor to discuss the potential risks and benefits of taking Otelza, to ensure it is the right choice for your specific situation.

Article Created by A.I.